SCHEMBL22553815

SCHEMBL22553815

O=C(Nc1ccccn1)c1cc2c(-c3cncc(-c4ccc(N5CCCC5=O)cc4)c3)ccnc2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.45
NUDT1 P36639 3/20 0.44
WNT1 P04628 2/20 0.41
DYRK1A Q13627 2/20 0.41
F10 P00742 4/20 0.41
NPC1 O15118 5/20 0.41
DGAT2 Q96PD7 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
TBK1 Q9UHD2 1/20 0.39
RAB9A P51151 4/20 0.39
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30730793 1.00 HPGDS (0.45) HPGDSNUDT1WNT1DYRK1AF10
SCHEMBL30730854 0.90 NPC1 (0.48) HPGDSNUDT1F10NPC1DGAT2
SCHEMBL22553987 0.90 NPC1 (0.48) HPGDSNUDT1F10NPC1DGAT2
SCHEMBL22554272 0.88 NUDT1 (0.48) HPGDSNUDT1WNT1DYRK1ANPC1
SCHEMBL30730800 0.88 NUDT1 (0.48) HPGDSNUDT1WNT1DYRK1ANPC1
SCHEMBL22553904 0.88 NPC1 (0.49) HPGDSNUDT1DYRK1AF10NPC1
SCHEMBL30730862 0.88 NPC1 (0.49) HPGDSNUDT1DYRK1AF10NPC1
SCHEMBL22554015 0.87 DGAT2 (0.43) HPGDSNUDT1NPC1DGAT2MEN1
SCHEMBL30730866 0.87 DGAT2 (0.43) HPGDSNUDT1NPC1DGAT2MEN1
SCHEMBL22554135 0.87 NUDT1 (0.57) HPGDSNUDT1NPC1DGAT2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US claimed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP claimed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1A, PIP5K1B, PIP5K1C HPGDS 4023/4885NUDT1 2148/4885WNT1 3680/4885
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C HPGDS 4023/4885NUDT1 2148/4885WNT1 3680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.